CFTR and cystic fibrosis: Although the use of molecular methods for CF-NBS helps to increase the sensitivity of the test, it is important to recognize the limitations of its use in countries with limited resources, low incidence of the disease, and especially a high rate of CFTR gene heterogeneity.